Drug Shortage Report for TEVA-VALSARTAN

Last updated on 2021-04-22 History
Report ID 137939
Drug Identification Number 02356686
Brand name TEVA-VALSARTAN
Common or Proper name VALSARTAN 320MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VALSARTAN
Strength(s) 320MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size P/P 30
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-21
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-04-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-04-22 French Compare
v1 2021-04-22 English Compare

Showing 1 to 2 of 2